Skip to main content

Table 6 Kaplan-Meier time-to-event estimates of clinical outcomes

From: A randomized, multi-center, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with hemodynamically relevant atherosclerotic renal artery stenosis (RADAR) – one-year results of a pre-maturely terminated study

  12 months 3 years
Stent
N (%)
(95% CI)
BMT
N (%)
(95% CI)
P value Stent
N (%)
(95% CI)
BMT
N (%)
(95% CI)
P value
MACCEa 1 (2.9) (0.4, 19.1) 2 (5.3) (1.3, 19.5) 0.526 4 (14.8) (5.8, 35.1) 3 (12.0) (3.5, 36.8) 0.982
Death 1 (2.3) (0.3, 15.4) 1 (3.1) (0.4, 20.2) 0.955 4 (13.8) (5.3, 33.3) 2 (9.2) (2.2, 34.1 0.639
Renal death 1 (2.2) (0.3, 14.7) 0 (0.0) 1.000 1 (2.2) (0.3, 14.7) 0 (0.0) 1.00
Cardiac death 0 (0.0) 0 (0.0) > 0.999 2 (7.9) (2.0, 28.1) 0 (0.0) (0.0, 0.0) 0.495
Stroke 1 (2.9) (0.4, 19.1) 1 (2.7) (0.4, 17.7) 0.966 1 (2.9) (0.4, 19.1) 2 (9.7) (2.2, 37.3) 0.447
Myocardial infarction 0 (0.0) 0 (0.0) > 0.999 1 (4.3) (0.6, 27.1) 0 (0.0) (0.0, 0.0) > 0.999
Hospitalization for congestive heart failure 0 (0.0) 1 (2.6) (0.4, 16.8) 0.477 1 (4.2) (0.6, 26.1) 1 (2.6) (0.4, 16.8) 0.855
Progressive renal insufficiency (i.e. need for dialysis) 1 (2.4) (0.3, 16.1) 1 (2.7) (0.4, 17.7) 0.978 1 (2.4) (0.3, 16.1) 1 (2.7) (0.4, 17.7) 0.978
Permanent renal replacement therapy 1 (2.4) (0.3, 16.1) 0 (0.0) > 0.999 1 (2.4) (0.3, 16.1) 0 (0.0) > 0.999
Target vessel (re)vascularization 1 (3.0) (0.4, 19.6) 4 (11.0) (4.3, 26.8) 0.142 1 (3.0) (0.4, 19.6) 8 (29.4) (15.4, 51.6) 0.008
Target lesion (re)vascularization 1 (3.0) (0.4, 19.6) 4 (11.0) (4.3, 26.8) 0.142 1 (3.0) (0.4, 19.6) 8 (29.4) (15.4, 51.6) 0.008
  1. Data are displayed as number (percentage) (95% CI). BMT best medical treatment, MACCE major adverse cardiac and cerebrovascular event
  2. aComposite of cardiac death, stroke, myocardial infarction and hospitalization for congestive heart failure